Swiss Rockets AG
Nadezda Gracheva has a Master Degree in Chemistry from Lomonosov Moscow State University (MSU). Nadezda went on to complete a PhD in Radiochemistry/Nuclear Medicine at ETH Zürich. Currently, Nadezda holds the position of Head Operations Nuclear Medicine and Clinical Scientist at Swiss Rockets AG since March 2020. Prior to this, Nadezda worked at ETH Zürich from November 2015 to October 2019.
This person is not in the org chart
Swiss Rockets AG
The Swiss Rockets mission is to deliver outstanding results for patients, inventors, and investors. Founded in 2018 in Basel, Swiss Rockets is implementing a paradigm shift in healthcare. Cancer patients will benefit from new treatment therapies developed using innovative and disruptive methods. The Swiss Rockets team combines the necessary specialist knowledge and experience to efficiently and sustainably break new ground in cancer medicine. We aim to set new paradigms in healthcare. Disruptive innovation in everything we do will allow us to deliver breakthrough treatments to patients with cancer. We conduct our business with the patients’ well-being in mind. Integrity, honesty, loyalty, and trust form the foundation on which we build our company and future success. All our investments, entrepreneurs, partners, and therapies always put the patients first. Our passion for people and patients makes us go at speed and with the power of rockets.